Dova Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dova Pharmaceuticals, Inc. - overview
Established
2005
Location
Durham, NC, US
Primary Industry
Pharmaceuticals
About
Founded in 2005 and based in New Carolina, US, Dova Pharmaceuticals, Inc. (f. k. a AkaRx, Inc.
) is a biopharmaceutical company that develops AKR-501, a therapeutic medicine for the treatment of thrombocytopenia.
Current Investors
InterWest Partners, Sutter Hill Ventures, PBM Capital Group
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceuticals
Website
www.dova.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Dova Pharmaceuticals, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPO | Completed | Dova Pharmaceuticals, Inc. | - | ||||||||
| Buyout | Completed | Dova Pharmaceuticals, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.